Holen Sie sich die Stockscreener-App
4.74
0.85%
0.04
Finanzdaten der Adverum Biotechnologies Inc-Aktie (ADVM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | 3.60 |
Operating Expenses
|
2.60%
26.84
|
26.16 | 34.53 | 33.06 | 33.84 |
| Depreciation and Amortization |
1.19%
0.997
|
1.009 | 1.509 | 1.534 | 1.592 |
| Operating Income/Loss |
2.60%
-26.84
|
-26.16 | -34.53 | -33.06 | -30.24 |
| Nonoperating Income/Loss |
56.52%
2.052
|
1.311 | 1.661 | 1.576 | 1.20 |
| Income/Loss From Continuing Operations Before Tax |
0.24%
-24.79
|
-24.85 | -32.87 | -31.49 | -29.04 |
| Income Tax Expense/Benefit |
100.00%
-
|
-1.133 | 0.017 | 0.021 | 0.017 |
| Income/Loss From Continuing Operations After Tax |
4.52%
-24.79
|
-23.71 | -32.88 | -31.51 | -29.06 |
|
Net Income/Loss
|
4.52%
-24.79
|
-23.71 | -32.88 | -31.51 | -29.06 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
12,479%
16.48
|
0.131 | 101.00 | 100.77 | 100.30 |
| Diluted Average Shares |
12,479%
16.48
|
0.131 | 101.00 | 100.77 | 100.30 |
| Basic Earnings Per Share |
552.17%
-1.50
|
-0.23 | -0.33 | -0.31 | -0.29 |
| Diluted Earnings Per Share |
552.17%
-1.50
|
-0.23 | -0.33 | -0.31 | -0.29 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):